01—Abstract
Summary
Summary of the 10-Q filed August 8, 2024. Cited figures are marked; the original filing is the authoritative source.
Tempur Sealy International, Inc. reported second-quarter 2024 net sales of $1,233.6 milliona, down from $1,269.7 million a year earlier, with the North America segment down 3.8% and International flat on a reported basis (up 1.9% on a constant currency basis).
Gross margin improved to 44.9% from 42.7%, and operating income rose to $173.3 millionb from $158.8 million. Net income attributable to Tempur Sealy was $106.1 million, or $0.60 per diluted share, versus $92.4 million, or $0.52, in the prior-year quarter. For the six months ended June 30, 2024, net sales were $2,423.0 million, down 2.2%, and net income attributable to the company was $182.4 million.
The company's principal pending event is its acquisition of Mattress Firm, a transaction valued at approximately $4.0 billionc, expected to be funded with about $2.7 billion of cash and 34.2 million shares. On July 2, 2024, the FTC filed a complaint and administrative action to challenge the deal, and on July 16, 2024 the court entered a temporary restraining order enjoining completion of the merger pending a ruling on a preliminary injunction. The merger agreement's termination date is February 9, 2025, and the company stated it intends to defend the lawsuit vigorously.
The company also suspended share repurchases in advance of closing the transaction. Balance sheet and liquidity remained solid: total debt was $2,505.8 milliond, the consolidated indebtedness less netted cash to adjusted EBITDA ratio was 2.70 times against a 5.00 times covenant limit, and total liquidity was $1,208.7 million. Cash flow from operations was $280.8 million for the six months, and capital expenditures were $60.0 million with full-year 2024 capital expenditures expected to be about $140 million.
02—Key points
Key Highlights
- Net sales declined 2.8% to $1,233.6 million in Q2 2024, with North America down 3.8% and International essentially flat (up 0.9% as reported).
- Gross margin rose to 44.9% from 42.7%, driven by favorable commodity costs, operational efficiencies and lower product launch costs in North America.
- Operating income increased 9.1% to $173.3 million; adjusted operating income rose 5.1% to $180.6 million.
- Diluted EPS increased 15.4% to $0.60 from $0.52; adjusted diluted EPS rose 8.6% to $0.63 from $0.58.
- The FTC filed suit on July 2, 2024 to block the Mattress Firm acquisition (~$4.0 billion), and a temporary restraining order was entered on July 16, 2024; the termination date is February 9, 2025.
- Total debt was $2,505.8 million and the leverage ratio was 2.70 times, within the 5.00 times covenant; liquidity totaled $1,208.7 million.
- Share repurchases were suspended pending the Mattress Firm closing, and the board declared a $0.13 per share dividend for Q3 2024.
03—One dollar
Follow one dollar
Of each $1.00 of revenue in Q2 FY2024, Somnigroup International kept $0.09.
- Revenue$1.23B100.0%
- Cost of revenue−$716.0M58.0%
- Gross profit$517.6M42.0%
- Operating costs−$344.3M27.9%
- Operating income$173.3M14.0%
- Interest, other & tax−$67.2M5.4%
- Net income$106.1M8.6%
04—Financials
Financial Highlights
Figures from 10-QQ2 FY2024filed August 8, 2024Financial Statements
Q2 FY2024 against Q2 FY2023
| Line item | Q2 FY2024Q2 FY2023 | Change |
|---|---|---|
| Revenue | $1.23B$1.27B | −2.8% |
| Cost of Revenue | $716.00M$727.40M | −1.6% |
| Gross Profit | $517.60M$542.30M | −4.6% |
| Operating Income | $173.30M$158.80M | +9.1% |
| Net Income | $106.10M$92.40M | +14.8% |
| EPS (Basic) | $0.61$0.54 | +13.0% |
| EPS (Diluted) | $0.60$0.52 | +15.4% |
| Shares Outstanding (Basic) | 173.70M172.10M | +0.9% |
| Shares Outstanding (Diluted) | 178.00M176.80M | +0.7% |
05—Questions
Frequently Asked Questions
What is the status of the Mattress Firm acquisition?
The FTC filed a complaint and administrative action on July 2, 2024 challenging the deal, and a temporary restraining order was entered on July 16, 2024 enjoining completion until the court rules on a preliminary injunction. The company believes litigation could be completed in the coming months, allowing a close in late 2024 or early 2025, and the merger agreement has a termination date of February 9, 2025.
Why did reported net sales decline in the quarter?
The filing attributes the North America decline, including a 4.6% drop in Wholesale sales, primarily to continued macroeconomic pressures affecting U.S. consumer behavior, partly offset by a 2.3% increase in Direct channel sales. International sales were roughly flat as reported and rose 1.9% on a constant currency basis.
How did profitability change in the second quarter?
Gross margin improved 220 basis points to 44.9%, mainly from favorable commodity costs and operational efficiencies in North America. Operating income grew to $173.3 million, and net income attributable to the company rose 14.8% to $106.1 million, though operating expenses increased in the International and North America segments.
Is the company's debt position under control?
As of June 30, 2024, the company was in compliance with all debt covenants. Total debt was $2,505.8 million, consolidated indebtedness less netted cash to adjusted EBITDA was 2.70 times against a maximum of 5.00 times, and the company had $1,112.9 million available under its revolving facility.
Will the company continue returning cash to shareholders?
The company declared a $0.13 per share dividend for the third quarter of 2024, payable August 29, 2024. It did not repurchase shares under its program in the first half of 2024 and temporarily suspended repurchases in advance of closing the Mattress Firm transaction, with $774.5 million remaining under its authorization.
06—Continue